April 29, 20244Abu Dhabi National Insurance Company’s Acquisition of Shares in Allianz Saudi Fransi Cooperative Insurance
May 10, 20244Mainstream Renewable Power and Revenuts Power’s 2.5GW Offshore Wind Project In Gippsland Region
May 9, 20244A&O Shearman Bolsters M&A and Real Estate With the Addition of Partners Emanuele Trucco and Andrea De Pieri in Italy
May 9, 20244Dechert Bolsters Fintech and Crypto Regulatory Expertise with Key Strategic Hire Neel Maitra
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
May 9, 20244A&O Shearman Bolsters M&A and Real Estate With the Addition of Partners Emanuele Trucco and Andrea De Pieri in Italy
May 9, 20244Dechert Bolsters Fintech and Crypto Regulatory Expertise with Key Strategic Hire Neel Maitra
Homepage North America North America Legal Chronicle Mirati Therapeutics’ Merger With Bristol Myers Squibb Mirati Therapeutics’ Merger With Bristol Myers Squibb October 10, 2023 Laura Testa Tagged: 10-10-2023 Amber Harezlak Annemarie Mierzejewski Annie Villanueva Ben Sharp Brianne Allan Bristol-Myers Squibb Daniel Wolf Emily Lichtenheld Graham Robinson Imran Malek Jonathan Davis Joseph Kyle Snapp Julia Knafo Katherine Nemeth Kevin Perron Kirkland & Ellis Laura Knoll Maria Raptis Maya Florence megadeals Mirati Therapeutics, Inc. Moshe Spinowitz Patricia Carson Peter Kanellias Resa Schlossberg Sara Zablotney Scott Price Simpson Thacher & Bartlett Skadden Sophia Hudson Timothy Nelson Vivek Ratnam Kirkland & Ellis LLP advised Bristol Myers Squibb, while Skadden, Arps, Slate, Meagher & Flom LLP advised Mirat on the deal. Bristol Myers Squibb (NYSE: BMY)… This content is for Standard 1 Year members only.Login Join Now